~ 1982 .02 : 고려대학교 의과대학 학사 ~ 1985 .02 : 고려대학교 대학원 의학 석사 ~ 1991 .02 : 고려대학교 대학원 의학 박사
경력
1995 .09 ~ 1997 .08 : 미국질병관리본부, 간염부서, 객원연구원 1992 .03 ~ : 고려대학교 구로병원 소화기내과 교수 2004 .10 ~ 2006 .09 : 고려대학교 구로병원 교육수련위원장 2006 .10 ~ 2007 .10 : 고려대학교 구로병원 소화기내과 과장 2006 .10 ~ 2007 .10 : 고려대학교 구로병원 진료부원장 2007 .11 ~ 2009 .10 : 고려대학교 구로병원 병원장
논문
[국외논문] (Durability of Antiviral Response in HBeAg-Positive Chronic Hepatitis B Patients | Who Maintained Virologic Response for One Year After Lamivudine Discontinuation)
[국외논문] (Value of the model for end-stage liver disease for predicting survival in hepatocellular carcinoma patients treated with transarterial chemoembolization)
[국외논문] (Tenofovir plus lamivudine as rescue therapy for adefovir-resistant chronic hepatitis B in hepatitis B e antigen-positive patients with liver cirrhosis)
[국외논문] (Genetic analysis of HAV strains isolated from patients with acute hepatitis in Korea)
[국외논문] (Clevudine is highly efficacious in hepatitis B e antigen-negative chronic hepatitis B with durable off-therapy viral suppression)
[국외논문] (Levels of hepatitis B virus (HBV) replication during the nonreplicative phase: HBV quantification by real-time PCR in Korea)
[국외논문] (Clinical outcomes of chronic hepatitis B patients with persistently detectable serum hepatitis B virus DNA during lamivudine therapy)
[국외논문] (Clevudine therapy for 24 weeks further reduced serum hepatitis B virus DNA levels and increased ALT normalization rates without emergence of viral breakthrough than 12 weeks of clevudine therapy)
[국외논문] (Twenty-four-week clevudine therapy showed potent and sustained antiviral activity in HBeAg-positive chronic hepatitis B)
[국외논문] (A 12-week clevudine therapy showed potent and durable antiviral activity in HBeAg-positive chronic hepatitis B)